Doximity shares double on AI search optimism

Shares of digital medical platform Doximity surged more than 100% at one point, according to data reported by CNBC. The sharp intraday rally was driven by investor sentiment regarding the company's artificial intelligence search capabilities, which market participants believe have unlocked significant profitability potential and expanded the firm's addressable market.

The digital health provider saw its valuation fluctuate wildly during the trading session as traders reacted to the perceived strategic shift. The market's enthusiasm centred on the idea that integrating AI search tools into its platform would not only enhance user engagement but also open new revenue streams by reaching a broader audience of medical professionals and patients.

While the specific closing price was not detailed in the initial reporting, the magnitude of the intraday move highlighted the market's appetite for healthcare technology companies that can demonstrate clear paths to monetising artificial intelligence. The perception of a "larger addressable market" suggests that investors are looking beyond Doximity's existing user base to include new segments that can be reached through improved search functionality.

This surge occurred against a backdrop of a US market that had previously been buoyed by major corporate events, including the SpaceX IPO debut in June 2026. However, the Doximity rally appears to be a distinct event driven by company-specific fundamentals and technological adoption rather than broader macroeconomic trends or geopolitical developments such as the Iran-US peace talks.

The move underscores the ongoing focus on how artificial intelligence is being integrated into vertical-specific platforms. For Doximity, the key narrative is no longer just about connectivity within the medical community, but about leveraging data and search capabilities to drive tangible financial returns and market expansion.